Mr. Davidson became one of our directors immediately after completion of the merger with ReAble Therapeutics, Inc. Mr. Davidson previously served as ReAble's Chief Executive Officer from October 2000 until the merger with ReAble and was Chairman of ReAble's board of directors from February 2001 to November 2006. Mr. Davidson also served as ReAble's President from October 2000 to May 2003 and again from November 2006 to the merger with ReAble. Mr. Davidson has served as a member of ReAble's board of directors since March 1997. Mr. Davidson served as Chairman, President and CEO of Maxxim Medical, Inc., a publicly-held medical supply company, from 1986 to July 2000. Previously, Mr. Davidson held various positions with Intermedics, Inc., a pacemaker equipment manufacturer, Baxter Laboratories, a publicly-held healthcare product and service company, and Merck & Co, a human and animal health care product company.

Ms. Kahr became one of our directors in November 2006 in connection with Blackstone's acquitions of our predecessor company, Encore Medical Corporation. Ms. Kahr is currently a principal of the Blackstone Group. Before joining Blackstone in 2004, Ms. Kahr was a Project Leader at the Boston Consulting Group, where she worked with companies in a variety of industries, including financial services, pharmaceuticals, media and entertainment, and consumer goods. Ms. Kahr is also the sole author of Working Knowledge, a book published by Simon & Schuster in 1998.

Mr. Chapman became one of our directors immediately after the completion of the merger with ReAble Therapeutics, Inc. Mr. Chapman previously served as ReAble's Chief Operating Officer since May 2003. Mr. Chapman previously served as Group President – Surgical and Rehabilitation from October 2006 and as ReAble's President from May 2003. Previously, Mr. Chapman served as ReAble's Executive Vice President and as President of Chattanooga Group Division, a position he accepted in February 2002 upon ReAble's acquisition of Chattanooga Group, Inc. From 1995 to February 2002, he served as Chief Executive Officer of Chattanooga Group, Inc. Prior to joining Chattanooga Group, Inc. in 1994, Mr. Chapman was employed by Stryker Corporation, a medical device manufacturer. During his six years at Stryker, Mr. Chapman held a variety of positions including Vice President and General Manager, Patient Care Division; Vice President of Marketing and New Business Development; Vice President of Sales, Medical Division; and Vice President of Operations, Medical Division.

Mr. Cross became our Chief Executive Officer and member of our Board of Directors immediately following the completion of the merger with ReAble Therapeutics, Inc. Mr. Cross was previously the Chief Executive Officer and President and a member of the board of directors of DJO Incorporated. He served as the Chief Executive Officer and a Manager of DonJoy, L.L.C., from June 1999 until November 2001, and has served as President of DJO, LLC, or its predecessor, the Bracing & Support Systems division of Smith & Nephew, Inc. since June 1995. From 1990 to 1994, Mr. Cross held the position of Senior Vice President of Marketing and Business Development of the Bracing & Support Systems division of Smith & Nephew. He was a Managing Director of two different divisions of Smith & Nephew from 1982 to 1990. Prior to that time, he worked at American Hospital Supply Corporation. Mr. Cross earned a diploma in medical technology from Sydney Technical College in Sydney, Australia and studied business at the University of Cape Town, South Africa.